Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Germany to Invest 500,000 Euros in Israeli Tech Start-Ups
Error: Contact form not found.
by JNS.org
Karl-Ludwig Kley, chairman and CEO of the Merck pharmaceutical company, led a delegation of 100 German government and business officials to Israel for Israel-Germany Innovation Day. Photo: Twitter.
JNS.org – Germany will be investing 500,000 euros ($559,000 or 2.1 million shekels) in Israeli initiatives through a program launched by the German government on Israel-Germany Innovation Day in Tel Aviv on Monday, which was held as part of the ongoing commemoration of 50 years of bilateral ties between the countries.
In addition, a delegation of 100 German government and business officials arrived in Israel on Monday, headed by Karl-Ludwig Kley, chairman and CEO of the Merck pharmaceutical company, who met with Israeli Economy and Trade Minister Aryeh Deri. Kley informed Deri that his company will be purchasing the last stake in the Israeli nanotechnology company Qlight Nanotech, Israel Hayomreported.
The purchase of Qlight Nanotech will transform its operations into Merck’s official research and development center in Israel, and will also increase the company’s output.
